An Anti-Biofilm Synergistic Framework for Treating Chronic Wounds
Lead Participant:
5D HEALTH PROTECTION GROUP LTD
Abstract
This project is a collaboration between the 5D Health Protection Group Ltd and the University of Liverpool
Clinical Engineering Department. The research and development collaboration will enable the development of
the next generation antibiofilm technologies that can be applied to medical platforms for enhancing clinical
outcome. One important area for use of this technology would be woundcare considering now that chronic
wounds have been shown to now contain biofilms. Many complex biofilms found in non-healing and infected
chronic wounds are recalcitrant to presently used antimicrobial interventions. Furthermore these interventions
are often overused and have no enhanced clinical benefit. In addition the project will involve the development
of a framework that involves the intelligent triggered release of synergistic agents for maximum impact and
reduced hospital costs. Presently such technology does not exist in the market so this innovation will create the
first world leading prototypes and advanced technolgies that presently do not deliver to the expectations
required for biofilm management in non-healing and infected chronic wounds.
Clinical Engineering Department. The research and development collaboration will enable the development of
the next generation antibiofilm technologies that can be applied to medical platforms for enhancing clinical
outcome. One important area for use of this technology would be woundcare considering now that chronic
wounds have been shown to now contain biofilms. Many complex biofilms found in non-healing and infected
chronic wounds are recalcitrant to presently used antimicrobial interventions. Furthermore these interventions
are often overused and have no enhanced clinical benefit. In addition the project will involve the development
of a framework that involves the intelligent triggered release of synergistic agents for maximum impact and
reduced hospital costs. Presently such technology does not exist in the market so this innovation will create the
first world leading prototypes and advanced technolgies that presently do not deliver to the expectations
required for biofilm management in non-healing and infected chronic wounds.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
5D HEALTH PROTECTION GROUP LTD | £67,158 | £ 47,011 |
  | ||
Participant |
||
INNOVATE UK |
People |
ORCID iD |
Martin Crowe (Project Manager) |